Clinical Trial Update: Repurposed Drugs to Improve Haematological Responses in Myelodysplastic Syndromes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring repurposed drugs to improve hematological responses in myelodysplastic syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Snippet

Sponsor: Prof. Janet Dunn | Conditions: Myelodysplastic Syndromes (MDS) | Phase 2 | Status: UNKNOWN